Potential Side Effects of AOD 9604 While AOD 9604 is generally well-tolerated, some individuals may experience:: Upset stomach Headaches Pain or redness at the injection site Always consult with a healthcare professional before starting any new treatment regimen
5-Amino-1MQ has been studied primarily in mouse models where it demonstrated notable fat loss, improved insulin sensitivity, and enhanced energy metabolism without reducing muscle mass
The clinical drug development program was halted in 2007 after the pivotal Phase IIb trial did not show statistically significant weight loss in the primary endpoint
Reported or possible side effects (anecdotal): Mild gastrointestinal discomfort Temporary increase in energy or alertness Mild fluctuations in appetite or hydration Potential interactions with other metabolic regulators Contraindications : Pregnant or breastfeeding individuals Patients with uncontrolled thyroid or adrenal disorders Individuals on insulin or glucose-lowering medications (unless medically supervised) Storage and Handling Store in a cool, dry place at 1525C (5977F) Keep container tightly closed Protect from light and moisture Keep out of reach of children For compounded or research use only , as directed by a licensed healthcare provider Why Choose 5-Amino-1MQ
It mimics the fat-burning region of growth hormone without triggering muscle growth or metabolic side effects
Why does Omnix offer 5-Amino-1MQ in a capsule format